Home >
World Cord Blood Congress IV and Innovative Therapies for Sickle Cell Disease World Cord Blood Congress IV and Innovative Therapies for Sickle Cell Disease
Chairs: E. Gluckman (Paris), M. Cavazzana (Paris)
Monaco – October 2013, 24-27
Session I: CORD BLOOD STEM CELL
Session II: METHODS OF GRAFT FACILITATION
- State of the art – E.J. Shpall
- Generation and expansion of human T-lymphoid progenitors from cord blood CD34+ cells in a feeder-cell-free DL-4 culture system – I. André-Schmutz
- Building myeloid bridges to enhance engraftment in cord blood transplant and beyond – C. Delaney
- Nicord expanded hematopoietic progenitor cells can outcompete the unmanipulated cord blood unit following myeloablative dual umbilical cord blood transplantation in adults with hematological malignancies – J. Kurtzberg
- Hematopoietic stem cell expansion to overcome non-engraftment – J. Wagner
Session III: NEW INNOVATIVE THERAPIES
Session IV: ROLE OF HLA AND OTHER GENETIC MARKERS
Session V: CORD BLOOD BANKING
Session VI: INTERNATIONAL OBSERVATORY ON SICKLE CELL DISEASE
- Sickle cell disease global perspective – E. Gluckman
- Hydroxycarbamide in the treatment of sickle cell disease – M. de Montalembert
- Is sickle cell disease an autonomic nervous system disorder: what triggers the transition from steady state to crisis? – T. Coates
- Sickle cell disease: genetic etiologies for phenotypic diversity – J. Elion
- Registry of pregnant women with sickle cell disease – M. Cavazzana
- Hematopoietic stem cell transplant for sickle cell disease – F. Bernaudin
- Haplo-identical related hematopoietic stem cell transplant for sickle cell disease – R. Jones
- New directions in allogeneic stem and cellular therapy in patients with sickle cell disease – M. Cairo
- Nicord expanded hematopoietic progenitor cells bridge hematopoiesis and facilitate engraftment after myeloablative chemotherapy for patients sickle cell disease – J. Kurtzberg
- Hematopoietic stem cell transplant for sickle cell disease in Brazil – B. Simoes
- Haemoglobinopathies and malaria in Africa – D. Diallo
- Epidemiology and treatment of sickle cell in Senegal including hydroxycarbamide, transfusions and chelation
in children – I. Diagne
in adults – S. Diop
- Long term outcome of paediatric patients undergoing haploidentical and matched related haematopoietic cell transplantation for sickle cell disease – M. Dallas
Session VII: HOW TO IMPROVE OUTCOME OF UNRELATED CORD BLOOD TRANSPLANT
Session VIII: COMPARISON OF CORD BLOOD TRANSPLANTS WITH OTHER SOURCES OF STEM CELLS
SATELLITE WORKSHOP ON SICKLE CELL DISEASE IN EMERGING COUNTRIES : 14:00 – 17:30
Session I: SICKLE CELL DISEASE IN EMERGING COUNTRIES
Session II: Words from the family support groups